Wilson
2006
Overview of sauropod phylogeny and evolution
RU2410386C2
(ru )
2011-01-27
Новые соединения, обладающие антибактериальной активностью
DE1377191U
(enExample )
Chuan-kuei et al.
1985
Possible phylogenetic relationship of Asiatic eurymylids and rodents, with comments on mimotonids
Cifelli
1993
Theria of metatherian-eutherian grade and the origin of marsupials
Matsumura et al.
1999
Metric analyses of an early Holocene human skeleton from Gua Gunung Runtuh, Malaysia
Ganesan et al.
2001
Obsessive—Compulsive Disorder and Psychosis
JP2004530736A5
(enExample )
2005-12-22
ATE541840T1
(de )
2012-02-15
Raloxifene-l-lactat oder ein hemihydrat davon, deren verwendungen, pharmazeutischen zusammensetzungen und herstellungsverfahren
Samuels et al.
2002
Improving accuracy in a computerized immunization registry
Marco
2009
New Iberian galliforms and reappraisal of some Pliocene and Pleistocene Eurasian taxa
Deng et al.
2003
On the existence and application of incomplete nearly Kirkman triple systems with a hole of size 6 or 12
Lawrence et al.
2004
Surveillance of adverse events following immunisation for children aged less than 7 years, 1 January to 30 June 2004
Nave et al.
2005
Lack of pharmacokinetic drug-drug interaction between ciclesonide and erythromycin.
Peralta-Mamani et al.
2024
CBCT vs panoramic radiography in assessment of impacted upper canine androot resorption of the adjacent teeth: A systematic review and meta-analysis
Xudoyarova et al.
2025
IMMUNITET NIMA VA U NIMA UCHUN KERAK?
DE1511444U
(enExample )
Maartens et al.
2020
THERAPEUTIC GUIDELINES SUB‐COMMITTEE RECOMMENDATION
Boisserie et al.
2014
A New Species of Nyanzachoerus (Cetartiodactyla: Suidae) from the Late Miocene
DE1376200U
(enExample )
Allegri et al.
2024
Editorial How to improve diversity and equity in clinical trials through telemedicine?
DE1417710U
(enExample )
Bettonte et al.
2022
Magnitude of Drug–Drug Interactions in Special Populations. Pharmaceutics 2022, 14, 789
Levine
1983
Modeling of the Collision Technique for Estimation of Motor Nerve Conduction Velocity Distributions in Human Peripheral Nerves
BR112022022107A2
(pt )
2023-02-28
Formulação farmacêutica de liberação modificada compreendendo hidroxipropilcelulose